What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
|Sep. 21||Weekly Gain||My Watchlist|
|IRIS International (Nasdaq: IRIS )||$19.47||45%||Add|
|Acadia Pharmaceuticals (Nasdaq: ACAD )||$2.62||24%||Add|
|NII Holdings (Nasdaq: NIHD )||$8.34||24%||Add|
|Complete Genomics (Nasdaq: GNOM )||$3.09||16%||Add|
|Nanosphere (Nasdaq: NSPH )||$3.79||15%||Add|
IRIS soared last week after receiving a buyout offer. Shareholders of the medical diagnostics provider will be cashed out at $19.50 a share in a tender offer.
Acadia Pharmaceuticals had a strong midweek run. Top-line results for the critical phase 3 study of a promising drug to treat Parkinson's-related psychosis are expected by the end of November. Expect plenty of volatile trading in the coming weeks as the company reaches that important revelation.
NII Holdings made a winning connection after CEO Steve Dussek increased his stake in the company, by 12%. It's a strong show of confidence for the Latin American wireless service provider.
Complete Genomics notched most of last week's gains on Monday, after the gene-sequencing specialist revealed that it would be acquired by China's BGI-Shenzhen. Complete Genomics had put itself up for sale when it initiated a strategic review earlier this year.
Nanosphere gained ground after the TheStreet.com published a bullish article on the provider of advanced molecular diagnostics systems. The shares also got a continued boost on Friday morning after announcing that its CFO would be speaking at an investor conference.
More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.